The Fragility of Statistically Significant Results in Randomized Clinical Trials for COVID-19

IMPORTANCE: Interpreting results from randomized clinical trials (RCTs) for COVID-19, which have been published rapidly and in vast numbers, is challenging during a pandemic. OBJECTIVE: To evaluate the robustness of statistically significant findings from RCTs for COVID-19 using the fragility index....

Descripción completa

Detalles Bibliográficos
Autores principales: Itaya, Takahiro, Isobe, Yotsuha, Suzuki, Sayoko, Koike, Kanako, Nishigaki, Masakazu, Yamamoto, Yosuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933746/
https://www.ncbi.nlm.nih.gov/pubmed/35302631
http://dx.doi.org/10.1001/jamanetworkopen.2022.2973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933746/
https://www.ncbi.nlm.nih.gov/pubmed/35302631
http://dx.doi.org/10.1001/jamanetworkopen.2022.2973

Ejemplares similares